Capricor Therapeutics, Inc. (CAPR)
NASDAQ: CAPR · Real-Time Price · USD
33.98
-1.12 (-3.19%)
At close: Apr 28, 2026, 4:00 PM EDT
34.00
+0.02 (0.06%)
After-hours: Apr 28, 2026, 7:52 PM EDT
Capricor Therapeutics Stock Forecast
Stock Price Forecast
The 8 analysts with 12-month price forecasts for Capricor Therapeutics stock have an average target of 44.63, with a low estimate of 13 and a high estimate of 63. The average target predicts an increase of 31.34% from the current stock price of 33.98.
Analyst Consensus: Strong Buy
* Price targets were last updated on Mar 13, 2026.
Analyst Ratings
The average analyst rating for Capricor Therapeutics stock from 8 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 5 | 5 | 5 | 5 | 5 |
| Buy | 2 | 3 | 3 | 3 | 3 | 3 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 6 | 8 | 8 | 8 | 8 | 8 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| B. Riley Securities | B. Riley Securities | Strong Buy Maintains $50 → $63 | Strong Buy | Maintains | $50 → $63 | +85.40% | Mar 13, 2026 |
| Piper Sandler | Piper Sandler | Buy Reiterates $45 → $58 | Buy | Reiterates | $45 → $58 | +70.69% | Mar 13, 2026 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $60 | Strong Buy | Reiterates | $60 | +76.57% | Mar 13, 2026 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $60 | Strong Buy | Reiterates | $60 | +76.57% | Mar 10, 2026 |
| B. Riley Securities | B. Riley Securities | Strong Buy Reiterates $21 → $50 | Strong Buy | Reiterates | $21 → $50 | +47.15% | Dec 15, 2025 |
Financial Forecast
Revenue This Year
118.80M
Revenue Next Year
122.73M
from 118.80M
Increased by 3.31%
EPS This Year
0.11
from -2.26
EPS Next Year
-0.06
from 0.11
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 294.0M | 223.7M | ||||||
| Avg | 118.8M | 122.7M | ||||||
| Low | n/a | 36.8M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | - | 88.3% | ||||||
| Avg | - | 3.3% | ||||||
| Low | - | -69.0% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 2.54 | 1.19 | ||||||
| Avg | 0.11 | -0.06 | ||||||
| Low | -2.31 | -1.67 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | - | 990.5% | ||||||
| Avg | - | - | ||||||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.